Healthcare Industry News: Elekta
News Release - April 7, 2006
Elekta Strengthens Stereotactic Planning PortfolioSTOCKHOLM, Sweden--(HSMN NewsFeed)--April 7, 2006--To further complement the Elekta (STO:EKTA) portfolio of stereotactic neurosurgery and radiation therapy solutions, an agreement with 3D Line Medical Systems allows Elekta to increase the range of stereotactic products offered to customers, including the 3D Line ERGO++ treatment planning system.
Elekta, a world leader in radiation oncology and non-invasive neurosurgery solutions, has this week signed a global marketing agreement with 3D Line Medical Systems, srl. The agreement allows Elekta to offer a complete stereotactic radiosurgery palette, including 3D Line's stereotactic cones and ERGO treatment planning system with all new Elekta digital accelerators. This agreement immediately enhances the stereotactic delivery products from Elekta, in particular by providing stereotactic planning opportunities for the Beam Modulator(TM).
The ERGO treatment planning system has a modular design that supports planning for classical stereotaxy, using circular (cylindrical) cones (collimators) in single and multi-fraction treatment delivery. The open systems philosophy of both companies means that virtually all commercial head and body frames are supported for stereotactic localization, including Leksell® Coordinate Frame G, Elekta Esarte(TM) Frame and Medical Intelligence localizers.
The ERGO planning system will be demonstrated on the Elekta booth at the 2006 American Association of Neurological Surgeons (AANS) meeting in San Francisco, April 23-27, providing planning support for the Elekta stereotactic head and body frame systems.
"With Elekta we have found a group of highly experienced people, sharing with us the passion to turn everyday clinical challenges into real solutions by combining research and innovation. Elekta and 3D Line have been working to export the classical stereotactic accuracy to any anatomical region. This partnership agreement combines the power of high performance imaging with superior stereotactic planning capabilities, to give rise to a new evolution of modern radiotherapy," says 3D Line Medical Systems CEO, Roberto Pellegrini.
Elekta Product Manager for IMRT and Treatment Planning, Nick Linton, added, "We have had an informal relationship with 3D Line for several years and have provided products and services to mutual customers in the field of radiation therapy planning. This agreement continues a successful relationship and expands the choice of options for those customers looking at stereotactic solutions, image guided radiation therapy and radiosurgery."
"We are very pleased to be able to offer 3D Line stereotactic planning and circular cones to enhance and support our stereotactic product offering across the range of Elekta Digital Accelerators. We expect that this will be a very beneficial relationship for our customers," concluded Sarah Edwards, Elekta Product Manager for Stereotactic Radiation Therapy.
About 3D Line
3D Line Medical Systems is an Italian international company active in the areas of Radiation Oncology, Medical Physics, Radiology and Surgery. With facilities in Milan (Italy), Reston (USA) and Nuernberg (Germany) we reach and support the medical community around the world, with our growing innovative product portfolio.
Founded in 1990, a collaboration between a group of talented computer science graduates and a neurosurgeon pioneering the use of computer-assisted techniques in the operating theatre, the company still maintains the original spirit. Many of our resources are devoted to research and development activities, conducted in combination with medical and scientific centers: side by side with doctors and field technicians, we learn how to improve existing techniques and develop new solutions. In Radiation Oncology and Surgery we have developed a keen awareness of the possibilities for providing precision treatments utilizing the technology of 3D graphics and computing combined with innovative engineering of hardware components.
Today, the organization operates globally also in terms of research partnerships with leading Universities and centers of excellence in different locations around the world.
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include among others Leksell Gamma Knife® for non-invasive treatment of brain surgery and Elekta Synergy® for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group is the world's largest supplier of oncology software.
Elekta's systems and solutions are used at over 3,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approx. 1800 employees, Elekta's corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta, please visit www.Elekta.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.